Jos Even
Impact in
- Immunology top 0.5%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 37
- Immunotherapy and Immune Responses 22
- T-cell and B-cell Immunology 22
- Immune Cell Function and Interaction 13
- Oncology 19
- CAR-T cell therapy research 10
- Cancer Immunotherapy and Biomarkers 7
- Co-authors
- Christophe Pannetier (9 shared papers)Philippe Kourilsky (11 shared papers)Philippe Kourilsky (1 shared paper)Véronique Baron (1 shared paper)Jean Kanellopoulos (1 shared paper)T. Petteri Arstila (1 shared paper)Armanda Casrouge (1 shared paper)John R. Wunderlich (1 shared paper)
- Journals
- Blood (8 papers)The Journal of Immunology (6 papers)European Journal of Immunology (4 papers)Human Immunology (3 papers)International Journal of Cancer (3 papers)
- Partner nations
- FranceUnited StatesLuxembourg
In The Last Decade
Jos Even
72 papers receiving 4.4k citations
Jos Even's Hit Papers
Peers
Comparison fields: 5 of 102
- Immunology 3.0k
- Oncology 1.2k
- Hematology 464
- Virology 130
- Radiology, Nuclear Medicine and Imaging 503
Countries citing papers authored by Jos Even
This map shows the geographic impact of Jos Even's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jos Even with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jos Even more than expected).
Fields of papers citing papers by Jos Even
This network shows the impact of papers produced by Jos Even. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jos Even. The network helps show where Jos Even may publish in the future.
Co-authors
The 25 scholars most cited alongside Jos Even, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Direct Estimate of the Human αβ T Cell Receptor Diversity Hit paper breakdown → | 1999 | 696 |
| 2 | Generation of Tumor-Infiltrating Lymphocyte Cultures for Use in Adoptive Transfer Therapy for Melanoma Patients Hit paper breakdown → | 2003 | 539 |
| 3 | 1995 | 479 | |
| 4 | 1997 | 239 | |
| 5 | 1994 | 213 | |
| 6 | 1988 | 157 | |
| 7 | 1996 | 145 | |
| 8 | 1999 | 130 | |
| 9 | 1998 | 124 | |
| 10 | 1995 | 103 | |
| 11 | 2002 | 92 | |
| 12 | 1981 | 76 | |
| 13 | 1994 | 72 | |
| 14 | 2008 | 68 | |
| 15 | 1985 | 63 | |
| 16 | 2014 | 57 | |
| 17 | 1999 | 48 | |
| 18 | Evidence for T-cell clonal expansion in a patient with squamous cell carcinoma of the head and neck. | 1994 | 48 |
| 19 | 2000 | 47 | |
| 20 | 1981 | 46 |
About Jos Even
Jos Even is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Hematology, having authored 72 papers that have together received 4.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (22 papers), T-cell and B-cell Immunology (22 papers), Monoclonal and Polyclonal Antibodies Research (19 papers), Immune Cell Function and Interaction (13 papers), CAR-T cell therapy research (10 papers), Virus-based gene therapy research (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Glycosylation and Glycoproteins Research (6 papers). The work is most often cited by research in Immunology (3.0k citations), Oncology (1.2k citations), Hematology (464 citations), Virology (130 citations) and Radiology, Nuclear Medicine and Imaging (503 citations). Jos Even has collaborated with scholars based in France, United States and Luxembourg. Frequent co-authors include Christophe Pannetier, Philippe Kourilsky, Philippe Kourilsky, Véronique Baron, Jean Kanellopoulos, T. Petteri Arstila, Armanda Casrouge, John R. Wunderlich, Mark E. Dudley and Thomas E. Shelton. Their work appears in journals such as Blood, The Journal of Immunology, European Journal of Immunology, Human Immunology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.